Statistics
Publications
120
Citations
15.4K
H-Index
53
Active since
2001
Xianming Deng is an author at Xiamen University specializing in medicinal chemistry, pharmacology, and molecular oncology.
Publications per year
2001–2025
120
120
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn et al. · Nature · 2012 · 2.6K citations · Full text
Medicine, Cancer Biology, Oncology +16
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio, Theo Knijnenburg, Daniël J. Vis et al. · Cell · 2016 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +17
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
Hongbin He, Hua Jiang, Yun Chen et al. · Nature Communications · 2018 · 791 citations · Full text
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang, Francisco Adrián, Wolfgang Jahnke et al. · Nature · 2010 · 599 citations
1–5 of 120